Managing Side Effects During Dose Titration: Week-by-Week Guide

Every GLP-1 medication requires dose titration — a carefully planned escalation from a low starting dose to your target therapeutic dose. Each step up can bring a temporary return of side effects as your body adapts to higher medication levels. This week-by-week guide covers what to expect at each stage and how to manage side effects so you stay on track.

Understanding the Titration Schedules

Semaglutide (Wegovy) Titration

• Weeks 1-4: 0.25mg weekly
• Weeks 5-8: 0.5mg weekly
• Weeks 9-12: 1.0mg weekly
• Weeks 13-16: 1.7mg weekly
• Week 17+: 2.4mg weekly (maintenance dose)

Tirzepatide (Zepbound) Titration

• Weeks 1-4: 2.5mg weekly
• Weeks 5-8: 5mg weekly
• Weeks 9-12: 7.5mg weekly
• Weeks 13-16: 10mg weekly
• Weeks 17-20: 12.5mg weekly
• Week 21+: 15mg weekly (maximum dose)

Not every patient reaches the maximum dose. Many achieve excellent results at intermediate doses. Your provider will help determine your optimal maintenance dose based on efficacy, tolerability, and your individual goals.

Phase 1: Starting Dose (Weeks 1-4)

Semaglutide 0.25mg / Tirzepatide 2.5mg

The starting dose is sub-therapeutic for weight loss — its primary purpose is to let your GI system adjust to the medication's mechanism before ramping up.

What to Expect

• Mild nausea (30-40%): Usually peaks 24-48 hours after injection, resolves by Day 4-5
• Appetite reduction (50-60%): Noticeable but gentle. You eat slightly less without feeling deprived.
• Mild fatigue (15-20%): Usually limited to 24-48 hours post-injection
• Minimal weight loss: 1-3 lbs, mostly from reduced food intake and water

Management Strategy

• Use this phase to establish good habits: hydration routine, smaller meal pattern, symptom diary
• Eat bland, easily digestible meals on injection day and the day after
• Begin taking a multivitamin if not already, to prevent nutritional gaps
• Establish an exercise routine — even walking 20 minutes daily

Phase 2: First Dose Increase (Weeks 5-8)

Semaglutide 0.5mg / Tirzepatide 5mg

This is often the most challenging titration step because the body is encountering a meaningfully higher medication level for the first time. However, your GI system has already been primed by the starting dose, so most patients handle it better than expected.

What to Expect

• Nausea returns temporarily (40-50%): Usually milder and shorter-lasting than Week 1. Peaks at 24-48 hours, resolves within 3-5 days.
• Stronger appetite suppression: This is where therapeutic appetite reduction truly begins. Portions shrink noticeably.
• Possible constipation (15-25%): As gastric emptying slows further
• Bloating and gas: May emerge or worsen at this dose
• Measurable weight loss begins: 3-6 lbs total from baseline by Week 8 is typical

Management Strategy

• If nausea was significant at 0.25mg, ask your provider about anti-nausea medication (ondansetron) as a bridge
• Increase fiber and water intake proactively to prevent constipation
• Begin magnesium supplementation (200-400mg citrate at bedtime) if constipation appears
• Prioritize protein — aim for at least 60g daily as appetite drops

Phase 3: Mid-Titration (Weeks 9-12)

Semaglutide 1.0mg / Tirzepatide 7.5mg

Many patients find this the "sweet spot" where significant appetite suppression and weight loss are occurring while side effects have largely stabilized. However, this is also where some patients encounter new side effects for the first time.

What to Expect

• Nausea: Typically mild and brief (1-2 days after dose increase). Many patients report no nausea at this stage.
• Significant weight loss: 8-12 lbs from baseline by Week 12 is typical for responders
• Possible hair thinning: Telogen effluvium may begin to appear as cumulative weight loss reaches significance
• Fatigue fluctuations: Some patients notice increased tiredness as caloric intake drops
• Changes in taste preferences: Many patients report reduced cravings for sweets and fatty foods

Management Strategy

• Get blood work checked: CBC, metabolic panel, thyroid function, vitamin D, B12, iron studies
• Increase protein intake target to 0.7-1.0g per pound of body weight
• Start biotin and zinc supplementation if hair concerns arise
• If weight loss is exceeding 3-4 lbs per week, discuss with your provider — too-rapid loss increases side effects

Phase 4: Higher Doses (Weeks 13-16+)

Semaglutide 1.7-2.4mg / Tirzepatide 10-15mg

At higher doses, most patients have already adapted to the medication, and new side effects are less common. However, the increased potency means that any side effects that do occur may be more pronounced.

What to Expect

• Minimal new GI side effects for most patients who tolerated lower doses well
• Maximum appetite suppression: Some patients report needing reminders to eat
• Steady weight loss: 1-2 lbs per week is typical at maintenance doses
• Possible gallbladder concerns: Rapid weight loss increases gallstone risk. Report right upper abdominal pain.
• Injection site reactions: May increase slightly at higher doses/volumes

Management Strategy

• Do not increase beyond your optimal dose — if 1.0mg semaglutide provides sufficient appetite control and weight loss, you may not need 2.4mg
• Monitor for nutritional deficiencies with regular blood work
• Ensure minimum caloric intake (1,200+ women, 1,500+ men) to prevent metabolic adaptation
• Consider strength training to preserve muscle mass during significant weight loss
• Report any right upper abdominal pain (possible gallbladder issues) promptly

Universal Titration Tips

What Helps at Every Dose Level

• Consistency: Inject on the same day and time each week
• Hydration: 64-80 oz daily, non-negotiable at every dose level
• Protein priority: Eat protein first at every meal
• Movement: Walk daily — 20-30 minutes minimum
• Sleep: 7-9 hours consistently. Poor sleep worsens every side effect.
• Symptom diary: Track side effects, meals, weight, and energy level weekly. This data is invaluable for your provider.

When to Delay a Dose Increase

Talk to your provider about staying at your current dose longer if:

• Nausea has not resolved at your current dose after 4 weeks
• You are vomiting more than once per week
• Constipation is severe despite treatment
• You are losing weight too rapidly (3+ lbs per week consistently)
• Fatigue is significantly impacting daily function
• You feel well and are achieving good results at your current dose

When to Step Back to a Lower Dose

• New side effects are severe and not improving after 2 weeks at the higher dose
• Quality of life is significantly impaired
• You cannot maintain adequate food and fluid intake
• Weight loss has stalled despite side effects (suggests the dose is causing too much GI stress without additional benefit)

The "Second-Dose Surprise"

An interesting phenomenon reported by many patients: the second injection at a new dose level often produces fewer side effects than the first. This is because the body has already begun adapting during the first week at the new dose. By the third and fourth injections at a given level, most patients have fully adapted.

This means that if your first week at a new dose is rough, the second week is very likely to be better. Resist the urge to give up or reduce your dose after just one difficult injection — give it at least 2 weeks unless side effects are severe.

Key Takeaways

• Dose titration is a gradual process designed to minimize side effects — follow the prescribed schedule exactly
• The first dose increase (Week 5) is often the most challenging transition
• Side effects at each new dose typically peak in Week 1 and resolve by Week 2-3
• Not every patient needs the maximum dose — work with your provider to find your optimal level
• Stepping back to a lower dose is always an option and is not a failure
• Consistent hydration, protein intake, and movement are the foundation of successful titration